Sasa quelpaertensis leaf extract inhibits colon cancer by regulating cancer cell stemness in vitro and in vivo

International Journal of Molecular Sciences

Volumn 16, Issue 5, 2015, Pages 9976-9997

  Min, Soo Jin ^a   Lim, Ji Ye ^a   Kim, Haeng Ran ^b   Kim, Se Jae ^c   Kim, Yuri ^a  

^a Ewha Womans University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

Cancer stem cells; Colon cancer; Differentiation; Sasa quelpaertensis Nakai leaf extract; Self renewal

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CYTOKERATIN 20; GLYCOGEN SYNTHASE KINASE 3BETA; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH1 RECEPTOR; PARA COUMARIC ACID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SASA QUELPAERTENSIS EXTRACT; TRANSCRIPTION FACTOR SOX2; TRICIN; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT PROTEIN; ANTINEOPLASTIC AGENT; DLK1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEIN; GSK3B PROTEIN, HUMAN; GSK3B PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PEPTIDE; PROM1 PROTEIN, HUMAN; PROM1 PROTEIN, MOUSE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR SOX;

ANIMAL EXPERIMENT; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL RENEWAL; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLANT LEAF; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; FEMALE; GENETICS; HT-29 CELL LINE; METABOLISM; SASA;

SASA;

AC133 ANTIGEN; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; BETA CATENIN; COLONIC NEOPLASMS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; GLYCOPROTEINS; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; PEPTIDES; PLANT EXTRACTS; PLANT LEAVES; RECEPTOR, NOTCH1; SASA; SOXB1 TRANSCRIPTION FACTORS;

EID: 84929340108     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16059976     Document Type: Article

References (62)

1. Ferlay, J.; Ervik, M.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bary, F. Cancer Incidence and Mortality Worldwide: Iarc Cancer Base; International Agency for Research on Cancer: Lyon, France, 2012.
2. Andre, T.; Boni, C.; Mounedji-Boudiaf, L.; Navarro, M.; Tabernero, J.; Hickish, T.; Topham, C.; Zaninelli, M.; Clingan, P.; Bridgewater, J. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 2004, 350, 2343–2351.
3. Clarke, M.F.; Dick, J.E.; Dirks, P.B.; Eaves, C.J.; Jamieson, C.H.; Jones, D.L.; Visvader, J.; Weissman, I.L.; Wahl, G.M. Cancer stem cells—Perspectives on current status and future directions: Aacr workshop on cancer stem cells. Cancer Res. 2006, 66, 9339–9344.
4. Saigusa, S; Tanaka, K.; Toiyama, Y.; Yokoe, T.; Okugawa, Y.; Ioue, Y.; Miki, C.; Kusunoki, M. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann. Surg. Oncol. 2009, 16, 3488–3498.
5. O’Brien, C.A.; Pollett, A.; Gallinger, S.; Dick, J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445, 106–110.
6. Fang, D.D.; Kim, Y.J.; Lee, C.N.; Aggarwal, S.; McKinnon, K.; Mesmer, D.; Norton, J.; Birse, C.E.; He, T.; Ruben, S.M. et al. Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br. J. Cancer 2010, 102, 1265–1275.
7. Keysar, S.B.; Jimeno, A. More than markers: Biological significance of cancer stem cell-defining molecules. Mol. Cancer Ther. 2010, 9, 2450–2457.
8. Dalerba, P.; Dylla, S.J.; Park, I.K.; Liu, R.; Wang, X.; Cho, R.W.; Hoey, T.; Gurney, A.; Huang, E.H.; Simeone, D.M. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 2007, 104, 10158–10163.
9. Wang, C.; Xie, J.; Guo, J.; Manning, H.C.; Gore, J.C.; Guo, N. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol. Rep. 2012, 28, 1301–1308.
10. Haraguchi, N.; Ohkuma, M.; Sakashita, H.; Matsuzaki, S.; Tanaka, F.; Mimori, K.; Kamohara, Y.; Inoue, H.; Mori, M. CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann. Surg. Oncol. 2008, 15, 2927–2933.
11. Trumpp, A.; Wiestler, O.D. Mechanisms of disease: Cancer stem cells—targeting the evil twin. Nat. Clin. Pract. Oncol. 2008, 5, 337–347.
12. Gupta, P.B.; Chaffer, C.L. Weinberg, R.A. Cancer stem cells: Mirage or reality? Nat. Med. 2009, 15, 1010–1012.
13. Smas, C.M.; Sul, H.S. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993, 73, 725–734.
14. Kim Y.; Lin, Q.; Zelterman, D.; Yun, Z. Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res. 2009, 69, 9271–9280.
15. Graham, V.; Khudyakov, J.; Ellis, P.; Pevny, L. SOX2 functions to maintain neural progenitor identity. Neuron 2003, 39, 749–765.
16. Sikandar, S.S.; Pate, K.T.; Anderson, S.; Dizon, D.; Edwards, R.A.; Waterman, M.L.; Lipkin, S.M. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res. 2010, 70, 1469–1478.
17. Groden, J.; Joslyn, G.; Samowitz, W.; Jones, D.; Bhattacharyya, N.; Spirio, L.; Thliveris, A.; Robertson, M.; Egan, S.; Meuth, M. et al. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res. 1995, 55, 1531–1539.
18. Liu, S.; Dontu, G.; Wicha, M.S. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 2005, 7, 86–95.
19. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127, 469–480.
20. Kim, Y.; Lin, Q.; Glazer, P.M.; Yun, Z. Hypoxic tumor microenvironment and cancer cell differentiation. Curr. Mol. Med. 2009, 9, 425–434.
21. Brahimi-Horn, C.; Pouyssegur, J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull. Cancer 2006, 93, E73–E80.
22. Okabe, S.; Takeuchi, K.; Takagi, K.; Shibata, M. Stimulatory effect of the water extract of bamboo grass (folin solution) on gastric acid secretion in pylorus-ligated rats. Jpn. J. Pharmacol. 1975, 25, 608–609.
23. Yang, J.H.; Lim, H.S.; Heo, Y.R. Sasa borealis leaves extract improves insulin resistance by modulating inflammatory cytokine secretion in high fat diet-induced obese C57/BL6J mice. Nutr. Res. Pract. 2010, 4, 99–105.
24. Ren, M.; Reilly, R.T.; Sacchi, N. Sasa health exerts a protective effect on Her2/NeuN mammary tumorigenesis. Anticancer Res. 2004, 24, 2879–2884.
25. Kang, S.I.; Shin, H.S.; Kim, H.M.; Hong, Y.S.; Yoon, S.A.; Kang, S.W.; Kim, J.H.; Ko, H.C.; Kim, S.J. Anti-obesity properties of a Sasa quelpaertensis extract in high-fat diet-induced obese mice. Biosci. Biotechnol. Biochem. 2012, 76, 755–761.
26. Shibata, M.; Fojii, M.; Yamaguchi, R. [Pharmacological studies on bamboo grass. IV. Toxicological and pharmacological effects of the extract (FIII) obtained from Sasa albomarginata Makino et Shibata (author’s transl)] (in Japanese). Yakugaku Zasshi 1979, 99, 663–668.
27. Kitamura, K.; Saitoh, T.; Matsuo, A.; Suyama, Y. Development of microsatellite markers for the dwarf bamboo species Sasa cernua and Sasa kurilensis (Poaceae) in northern japan. Mol. Ecol. Resour. 2009, 9, 1470–1472.
28. Seki, T.; Maeda, H. Cancer preventive effect of kumaizasa bamboo leaf extracts administered prior to carcinogenesis or cancer inoculation. Anticancer Res. 2010, 30, 111–118.
29. Tsunoda, S.; Yamamoto, K.; Sakamoto, S.; Inoue, H.; Nagasawa, H. Effects of Sasa Health, extract of bamboo grass leaves, on spontaneous mammary tumourigenesis in SHN mice. Anticancer Res. 1998, 18, 153–158.
30. Kim, M.; Kim, Y.S.; Kim, K.M.; Ko, H.C.; Kim, S.J.; Kim, J.H.; Kim, Y. Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells. Integr. Cancer Ther. 2014, 13, 529–540.
31. An, S.M.; Lee, S.I.; Choi, S.W.; Moon, S.W.; Boo, Y.C. p-Coumaric acid, a constituent of Sasa quelpaertensis Nakai, inhibits cellular melanogenesis stimulated by alpha-melanocyte stimulating hormone. Br. J. Dermatol. 2008, 159, 292–299.
32. Byun, K.M. Apoptotic effect of Sasa quelpaertensis Nakai human colon cancer HT 29. J. Life Sci. 2014, 24, 1012–1018.
33. Hemmati, H.D.; Nakano, I.; Lazareff, J.A.; Masterman-Smith, M.; Geschwind, D.H.; Bronner-Fraser, M.; Kornblum, H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100, 15178–15183.
34. Vermeulen, L.; de Sousa, E.M.F.; van der Heijden, M.; Cameron, K.; de Jong, J.H.; Borovski, T.; Tuynman, J.B.; Todaro, M.; Merz, C.; Rodermond, H. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12, 468–476.
35. Liu, C.; Li, Y.; Semenov, M.; Han, C.; Baeg, G.H.; Tan, Y.; Zhang, Z.; Lin, X.; He, X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108, 837–847.
36. Pap, M.; Cooper, G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 1998, 273, 19929–19932.
37. Chen, K.L.; Pan, F.; Jiang, H.; Chen, J.F.; Pei, L.; Xie, F.W.; Liang, H.J. Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells. Clin. Exp. Metastasis 2011, 28, 751–763.
38. Guruvayoorappan, C.; Kuttan, G. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integr. Cancer Ther. 2007, 6, 258–270.
39. Das, B.; Tsuchida, R.; Malkin, D.; Koren, G.; Baruchel, S.; Yeger, H. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 2008, 26, 1818–1830.
40. Jogi, A.; Ora, I.; Nilsson, H.; Lindeheim, A.; Makino, Y.; Poellinger, L.; Axelson, H.; Pahlman, S. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. USA 2002, 99, 7021–7026.
41. Couvelard, A.; O’Toole, D.; Turley, H.; Leek, R.; Sauvanet, A.; Degott, C.; Ruszniewski, P.; Belghiti, J.; Harris, A.L.; Gatter, K. et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: Negative correlation of microvascular density and vegf expression with tumour progression. Br. J. Cancer 2005, 92, 94–101.
42. Saunders, M.; Iveson, T. Management of advanced colorectal cancer: State of the art. Br. J. Cancer 2006, 95, 131–138.
43. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71–96.
44. Boman, B.M.; Wicha, M.S. Cancer stem cells: A step toward the cure. J. Clin. Oncol. 2008, 26, 2795–2799.
45. Todaro, M.; Francipane, M.G.; Medema, J.P.; Stassi, G. Colon cancer stem cells: Promise of targeted therapy. Gastroenterology 2010, 138, 2151–2162.
46. Li, C.Y.; Li, B.X.; Liang, Y.; Peng, R.Q.; Ding, Y.; Xu, D.Z.; Zhang, X.; Pan, Z.Z.; Wan, D.S.; Zeng, Y.X. et al. Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIb. J. Transl. Med. 2009, 7, 56, doi:10.1186/1479-5876-7-56.
47. Seki, T.; Kida, K.; Maeda, H. Immunostimulation-mediated anti-tumor activity of bamboo (Sasa senanensis) leaf extracts obtained under “vigorous” condition. Evid. Based Complement. Altern. Med. 2010, 7, 447–457.
48. Kim J.H.; Kim, K.M. Antiproliferative and apoptotic effects of Sasa quelpaertensis Nakia in human cancer cells. J. Life Sci. 2014, 24, 903–909.
49. Ryu, M.J.; Cho, M.; Song, J.Y.; Yun, Y.S.; Choi, I.W.; Kim, D.E.; Park, B.S.; Oh, S. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem. Biophys. Res. Commun. 2008, 377, 1304–1308.
50. Li, Y.; Zhang, T.; Korkaya, H.; Liu, S.; Lee, H.F.; Newman, B.; Yu, Y.; Clouthier, S.G.; Schwartz, S.J.; Wicha, M.S. et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin. Cancer Res. 2010, 16, 2580–2590.
51. Demers, M.J.; Thibodeau, S.; Noel, D.; Fujita, N.; Tsuruo, T.; Gauthier, R.; Arguin, M.; Vachon, P.H. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1. J. Cell. Biochem. 2009, 107, 639–654.
52. De Carlo, F.; Witte, T.R.; Hardman, W.E.; Claudio, P.P. Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS ONE 2013, 8, e69760.
53. Lee, H.A.; Park, S.; Kim, Y. Effect of β-carotene on cancer cell stemness and differentiation in SK-N-BE(2)C neuroblastoma cells. Oncol. Rep. 2013, 30, 1869–1877.
54. Kim, K.M.; Kim, Y.S.; Lim, J.Y.; Min, S.J.; Ko, H.C.; Kim, S.J.; Kim, Y. Intestinal anti-inflammatory activity of Sasa quelpaertensis leaf extract by suppressing lipopolysaccharide-stimulated inflammatory mediators in intestinal epithelial Caco-2 cells co-cultured with RAW 264.7 macrophage cells. Nutr. Res. Pract. 2015, 9, 3–10.
55. Toll, A.D.; Boman, B.M.; Palazzo, J.P. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase. Hum. Pathol. 2012, 43, 238–242.
56. Suzuki, S.; Saito, T.; Uchiyama, M.; Akiya, S. Studies on the anti-tumor activity of polysaccharides. I. Isolation of hemicelluloses from yakushima-bamboo and their growth inhibitory activities against sarcoma-180 solid tumor. Chem. Pharm. Bull. 1968, 16, 2032–2039.
57. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768–780.
58. Zhao, M.; Yang, B.; Wang, J.; Liu, Y.; Yu, L.; Jiang, Y. Immunomodulatory and anticancer activities of flavonoids extracted from litchi (Litchi chinensis Sonn.) pericarp. Int. Immunopharmacol. 2007, 7, 162–166.
59. Mates, J.M.; Segura, J.A.; Alonso, F.J.; Marquez, J. Natural antioxidants: Therapeutic prospects for cancer and neurological diseases. Mini Rev. Med. Chem. 2009, 9, 1202–1214.
60. Mates, J.M.; Segura, J.A.; Alonso, F.J.; Marquez, J. Anticancer antioxidant regulatory functions of phytochemicals. Curr. Med. Chem. 2011, 18, 2315–2338.
61. Shi, J.; Kakuda, Y.; Yeung, D. Antioxidative properties of lycopene and other carotenoids from tomatoes: Synergistic effects. Biofactors 2004, 21, 203–210.
62. Liu, R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 2003, 78, 517S–520S.